CD Private Equity Fund III (ASX:CD3) has disclosed an estimated unaudited net tangible asset value after tax of $1.47 per unit as at 31 October 2026, compared with $1.50 per unit as at 30 September 2026, according to the fund's monthly NTA update released on 13 November 2026.

Key Points

  • Estimated unaudited NTA after tax at 31 October 2026 was $1.47 per unit, compared with $1.50 per unit at 30 September 2026
  • Gross assets stood at $109.0 million, with fund inception in July 2016
  • Distributions of $0.16 per unit were paid over the last 12 months; total distributions since inception were $2.299 per unit
  • Since inception annualised NTA return of 11.1% per annum; five-year annualised NTA return of 9.1% per annum
  • Since inception, CD3 has delivered an annualised IRR of 12.2%

October 2026 NTA Figures and Performance Summary

The estimated unaudited NTA before tax at 31 October 2026 was $1.51 per unit, compared with $1.54 per unit at 30 September 2026. The fund recorded a one-month NTA return of -2.0%, a six-month return of 2.0%, and a one-year return of -6.7%. Over three years the annualised return was 1.3%, over five years 9.1% per annum, and since inception 11.1% per annum. Total returns are inclusive of distributions and are based on the fund's post-tax NTA. The AUD:USD spot rate used in the calculation was 0.7030 as at 31 October 2026.

Foreign Exchange Impact on Monthly Movement

According to the filing, the movement in NTA during October 2026 primarily reflects foreign exchange losses resulting from the strengthening Australian dollar. The responsible entity of the fund is K2 Asset Management Ltd, which has been the source of performance data since 24 June 2023. Data prior to that date was sourced from E&P Investments Limited. The filing notes that numbers may not sum due to rounding, and that historical performance is not a guarantee of the future performance of the fund.

Capital Call and Fund Activity During October

During October 2026, the limited partnership received a capital call of approximately US$0.03 million for additional investments and ongoing fund expenses. The fund has gross assets of $109.0 million and has been operating since its inception in July 2016. Distributions paid to unitholders over the last 12 months totalled $0.16 per unit, while cumulative distributions since inception reached $2.299 per unit. Since inception, CD3 has delivered an annualised internal rate of return of 12.2%, as disclosed in the filing.